E-LIB Suche - Ergebnisse für: Viti, Raffaella

1

Cost-Effectiveness of Vedolizumab as a First-Line Advanced ..:

Salcedo, Jonathan ; Hill-McManus, Daniel ; Hardern, Chloë...
PharmacoEconomics - Open. , 2024

Link: https://doi.org/10.1007/..

2

Cost per responder for vedolizumab and ustekinumab in Crohn..:

Ravasio, Roberto ; Viti, Raffaella ; Roscini, Antonio Saverio
AboutOpen. 10 (2023) - p. 13-21 , 2023

Link: https://doi.org/10.33393..

3

[Burden of Short Bowel Syndrome in Italy: Direct and Indire..:

Mennini, Francesco Saverio ; Bini, Chiara ; Paoletti, Martina...
Farmeconomia. Health economics and therapeutic pathways. 24 (2023) 1 - p. , 2023

Link: https://doi.org/10.7175/..

4

Cost-utility analysis of brigatinib compared to alectinib i..:

Ravasio, Roberto ; Cranmer, Holly ; Kearns, Izzie..
AboutOpen. 9 (2022) - p. 92-104 , 2022

Link: https://doi.org/10.33393..

5

Forty-year investigations on apricot blooming: Evidences of..:

Bartolini, Susanna ; Massai, Rossano ; Iacona, Calogero..
Scientia Horticulturae. 244 (2019) - p. 399-405 , 2019

Link: https://doi.org/10.1016/..

6

Epidemiological and economic evaluations according to DAA t..:

Vella, Stefano ; Kondili, Loreta ; Marcellusi, Andrea...
Journal of Virus Eradication. 4 (2018) - p. 25-26 , 2018

Link: https://doi.org/10.1016/..

7

PD56 Economic Evaluation Of Dalbavancin In European Countri..:

Viti, Raffaella ; Marcellusi, Andrea ; Sarmati, Loredana...
International Journal of Technology Assessment in Health Care. 34 (2018) S1 - p. 149-150 , 2018

Link: https://doi.org/10.1017/..

8

Economic burden of schizophrenia in Italy: a probabilistic ..:

Marcellusi, Andrea ; Fabiano, Gianluca ; Viti, Raffaella...
BMJ Open. 8 (2018) 2 - p. e018359 , 2018

Link: https://doi.org/10.1136/..

9

Economic burden of disease of uncontrolled acromegalic pati..:

Mennini, Francesco S. ; Viti, Raffaella ; Bini, Chiara..
Global and Regional Health Technology Assessment. 5 (2018) 1 - p. , 2018

Link: https://doi.org/10.33393..

10

Direct and Indirect Costs of Immunoglobulin Replacement The..:

Viti, Raffaella ; Marcellusi, Andrea ; Capone, Alessandro...
Clinical Drug Investigation. 38 (2018) 10 - p. 955-965 , 2018

Link: https://doi.org/10.1007/..

11

Economic evaluation of spondyloarthritis: economic impact o..:

Mennini, Francesco S ; Viti, Raffaella ; Marcellusi, Andrea...
ClinicoEconomics and Outcomes Research. 10 (2018) - p. 45-51 , 2018

Link: https://doi.org/10.2147/..

12

Economic Consequences of Investing in Anti-HCV Antiviral Tr..:

PITER Collaborating group available at www.progettopiter.it ; Marcellusi, Andrea ; Viti, Raffaella...
PharmacoEconomics. 37 (2018) 2 - p. 255-266 , 2018

Link: https://doi.org/10.1007/..

13

Budget Impact analysis of the first-line treatment of Phila..:

Mennini, Francesco ; Marcellusi, Andrea ; Viti, Raffaella.
Farmeconomia. Health economics and therapeutic pathways. 18 (2017) 1 - p. , 2017

Link: https://doi.org/10.7175/..

14

Early Treatment in HIV Patients: A Cost–Utility Analysis fr..:

Marcellusi, Andrea ; Viti, Raffaella ; Russo, Simone...
Clinical Drug Investigation. 36 (2016) 5 - p. 377-387 , 2016

Link: https://doi.org/10.1007/..

15

The PPARγ2 P12A polymorphism is not associated with all-cau..:

Pacilli, Antonio ; Prudente, Sabrina ; Copetti, Massimiliano...
Endocrine. 54 (2016) 1 - p. 38-46 , 2016

Link: https://doi.org/10.1007/..